Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1982 2
1983 6
1984 3
1985 8
1986 4
1987 9
1988 5
1989 5
1990 9
1991 2
1992 3
1993 11
1994 4
1995 3
1996 4
1997 6
1998 3
1999 7
2000 2
2001 5
2002 6
2003 4
2004 4
2005 6
2006 1
2007 4
2008 4
2009 3
2010 4
2011 5
2012 4
2013 3
2014 2
2016 3
2017 3
2018 1
2019 1
2020 1
2021 1
2022 2
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Results by year
Filters applied: . Clear all
Page 1
Genetic Atypical Hemolytic-Uremic Syndrome.
Noris M, Bresin E, Mele C, Remuzzi G. Noris M, et al. 2007 Nov 16 [updated 2021 Sep 23]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. 2007 Nov 16 [updated 2021 Sep 23]. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 20301541 Free Books & Documents. Review.
CLINICAL CHARACTERISTICS: Hemolytic-uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia, and renal failure caused by platelet thrombi in the microcirculation of the kidney and other organs. ...Individuals with known aHUS should …
CLINICAL CHARACTERISTICS: Hemolytic-uremic syndrome (HUS) is characterized by hemolytic anemia, thrombocytopenia …
Mitomycin-C induced hemolytic uremic syndrome: a case report and literature review.
Wu DC, Liu JM, Chen YM, Yang S, Liu SM, Chen LT, Whang-Peng J. Wu DC, et al. Jpn J Clin Oncol. 1997 Apr;27(2):115-8. doi: 10.1093/jjco/27.2.115. Jpn J Clin Oncol. 1997. PMID: 9152802 Review.
Mitomycin-C is, etiologically, the most common causative agent inducing hemolytic uremic syndrome, in a dose dependent manner. ...Hemolytic uremic syndrome was diagnosed three months after the last dose of mitomycin-C admini …
Mitomycin-C is, etiologically, the most common causative agent inducing hemolytic uremic syndrome, in a dose dep …
Hemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.
D'Elia JA, Aslani M, Schermer S, Cloud L, Bothe A, Dzik W. D'Elia JA, et al. Ren Fail. 1987;10(2):107-13. doi: 10.3109/08860228709056324. Ren Fail. 1987. PMID: 3120247 Review.
Acute renal failure proved fatal in a patient with metastatic breast adenocarcinoma, complicated by the hemolytic-uremic syndrome. Low-grade hemolysis probably was ongoing prior to a third course of chemotherapy that included mitomycin. ...Schiztocytes …
Acute renal failure proved fatal in a patient with metastatic breast adenocarcinoma, complicated by the hemolytic-uremic sy …
Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution.
Glezerman I, Kris MG, Miller V, Seshan S, Flombaum CD. Glezerman I, et al. Clin Nephrol. 2009 Feb;71(2):130-9. doi: 10.5414/cnp71130. Clin Nephrol. 2009. PMID: 19203505
BACKGROUND: Gemcitabine is used in a variety of advanced malignancies. Hemolytic uremic syndrome has been reported as a side effect. METHODS: we reviewed medical records of 29 patients with gemcitabine nephrotoxicity. RESULTS: The median cumulative dose of ge …
BACKGROUND: Gemcitabine is used in a variety of advanced malignancies. Hemolytic uremic syndrome has been reported as a …
Hemolytic uremic syndrome.
Camp-Sorrell D. Camp-Sorrell D. Oncol Nurs Forum. 2008 Jul;35(4):593-6. doi: 10.1188/08.ONF.593-596. Oncol Nurs Forum. 2008. PMID: 18591164 Review. No abstract available.
Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature.
Saif MW, McGee PJ. Saif MW, et al. JOP. 2005 Jul 8;6(4):369-74. JOP. 2005. PMID: 16006690 Review.
CONTEXT: Hemolytic uremic syndrome is a rare condition compromising the clinical triad of acute renal failure, microangiopathic hemolytic anemia, and thrombocytopenia. Hemolytic uremic syndrome may be associated with a variety of e …
CONTEXT: Hemolytic uremic syndrome is a rare condition compromising the clinical triad of acute renal failure, microang …
[Mitomycin-induced hemolytic-uremic syndrome].
Zeller G, Wandel E, Schwarting A. Zeller G, et al. Dtsch Med Wochenschr. 2003 Jun 20;128(25-26):1399-402. doi: 10.1055/s-2003-40105. Dtsch Med Wochenschr. 2003. PMID: 12813674 German.
HISTORY AND CLINICAL FINDINGS: A 58-year-old patient suffered from rapidly progressing renal insufficiency and 11 kg weight-loss three months after adjuvant treatment of a carcinoma of the lower bowel (G 2 T 3 N 1 M 0 ) with mitomycine C. At the point of hospitalisation th …
HISTORY AND CLINICAL FINDINGS: A 58-year-old patient suffered from rapidly progressing renal insufficiency and 11 kg weight-loss three month …
Mitomycin C-induced hemolytic uremic syndrome. Six case reports and review of the literature on renal, pulmonary and cardiac side effects of the drug.
Verweij J, van der Burg ME, Pinedo HM. Verweij J, et al. Radiother Oncol. 1987 Jan;8(1):33-41. doi: 10.1016/s0167-8140(87)80020-8. Radiother Oncol. 1987. PMID: 3101142 Review.
Six new cases of mitomycin C (MMC)-induced hemolytic uremic syndrome are reported and the literature on renal-, pulmonary- and cardiotoxicity of the drug is reviewed. ...
Six new cases of mitomycin C (MMC)-induced hemolytic uremic syndrome are reported and the literature on renal-, …
Outcome of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan.
Mori Y, Wada H, Tamaki S, Minami N, Shiku H, Ihara T, Omine M, Kakisita E. Mori Y, et al. Clin Appl Thromb Hemost. 1999 Apr;5(2):110-2. doi: 10.1177/107602969900500206. Clin Appl Thromb Hemost. 1999. PMID: 10725990 Free article.
We examined 159 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan. The subjects were divided in three groups; 90 patients with thrombotic thrombocytopenic purpura, 51 patients with verotoxin-induced hemolytic u …
We examined 159 patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in Japan. The subjects …
Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature.
Lee HW, Chung MJ, Kang H, Choi H, Choi YJ, Lee KJ, Lee SW, Han SH, Kim JS, Song SY. Lee HW, et al. Gut Liver. 2014 Jan;8(1):109-12. doi: 10.5009/gnl.2014.8.1.109. Epub 2014 Jan 13. Gut Liver. 2014. PMID: 24516709 Free PMC article. Review.
Hemolytic uremic syndrome (HUS) is a rare thrombotic complication characterized by a triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure. HUS may be caused by several different conditions, including infection, malignan …
Hemolytic uremic syndrome (HUS) is a rare thrombotic complication characterized by a triad of microangiopathic hemol …
158 results